Fulgent Genetics (Fulgent Genetics) Short-Term Debt & Capital Lease Obligation : $5.1 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Fulgent Genetics Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Fulgent Genetics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.1 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Fulgent Genetics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $10.1 Mil.

Fulgent Genetics Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Fulgent Genetics's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Short-Term Debt & Capital Lease Obligation Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

0.42

15.02

21.28

26.77

5.14

Fulgent Genetics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															26.77	20.61	4.56	2.89	5.14

Fulgent Genetics Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Fulgent Genetics Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (Fulgent Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (NAS:FLGT) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

7F0:Germany 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Executives

Jian Xie	officer: Chief Operating Officer	C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVE, EL MONTE CA 91731
Hanlin Gao	10 percent owner, officer: Chief Scientific Officer	4399 SANTA ANITA AVE., EL MONTE CA 91731
Paul Kim	officer: CFO and Treasurer	4399 SANTA ANITA AVE, EL MONTE CA 91731
Regina E Groves	director	5751 COPLEY DRIVE, SAN DIEGO CA 92111
Leonard E Post	director
Michael Nohaile	director	C/O BIO AI ACCELERATION COMPANY, 20 UNIVERSITY AVENUE, CAMBRIDGE MA 02138
John C Bolger	director	4978 SANTA ANITA AVENUE, SUITE 205, TEMPLE CITY CA 91780
Ming Hsieh Trust	10 percent owner	4399 SANTA ANITA AVE., EL MONTE CA 91731
Linda Marsh	director	100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Ming Hsieh	director, 10 percent owner, officer: President and CEO	4399 SANTA ANITA AVE., EL MONTE CA 91731
Fulgent Genetics, Inc.	director	4399 SANTA ANITA AVE, EL MONTE CA 91731
Yun Yen	director	1301 OAKLAWN ROAD, ARCADIA CA 91006
James Mulay	director	6521 THOROUGHBRED LOOP, ODESSA FL 33556
Xi Long Usa, Inc.	10 percent owner	#6 XINRUI RD., SCIENCE CITY, LUOGANG DISTRICT, GUANGZHOU CITY F4 510663